Dr. Quay is consistently featured in the news and press. Here are some of the latest stories:

SARS-CoV-2 was spreading in the United States in late December 2019 and may have killed over 440 patients in California and 980 nationwide by mid-January 2020

May 29, 2020

Dr. Quay announces availability of his COVID-19 Survival Manual on June 5th SEATTLE, May 29, 2020 (GLOBENEWSWIRE) - Dr. Steven...

Know More

Atossa Therapeutics Announces Successful In vitro Testing Results of Coronavirus Drug: AT-H201 Inhibits SARS-CoV-2 Infectivity of VERO Cells in Laboratory Culture

May 22, 2020

Results Support Development of AT-H201 for COVID-19 Patients. SEATTLE, May 20, 2020 (GLOBE NEWSWIRE)

Know More

Atossa Therapeutics Contracts with NYC Health + Hospitals/Metropolitan for Coronavirus HOPE Clinical Study

Apr 27, 2020

Study Designed to Evaluate Atossa's Combination Therapy AT-H201 to Reduce Patient Time on a Ventilator

Know More

KIRO7: Seattle doctor developing treatment for sickest Coronavirus patients

Apr 21, 2020

SEATTLE — The fatality rate for COVID-19 victims on ventilators has been 50% or higher. So, at Atossa Therapeutics in...

Know More

Atossa Therapeutics Seeks Clinical Investigation Approval from FDA to Launch the Coronavirus HOPE Study

Apr 20, 2020

The COVID-19 HOPE trial is the first pharmaceutical study to address getting patients off mechanical ventilator and reducing the high...

Know More

Coronavirus “Cease Fire” for the United States on April 23, 2020 and successful ‘Opening Up America Again’ initiative predicted

Apr 17, 2020

U.S. Physician Scientist Dr. Steven Quay, MD, PhD offers his predictions based on Coronavirus case growth model

Know More

Dr. Quay talks to ABC7 about the Coronavirus HOPE Clinical Trial

Apr 10, 2020


Know More

FOX NEWS: Atossa Therapeutics leading clinical trial that may improve pulmonary function in Coronavirus patients

Apr 06, 2020


Know More

Stay up to date with Dr. Quay’s latest news!

Sign Up to Stay Informed